Aravive, Inc.·4

Jan 24, 4:18 PM ET

McIntyre Gail Frances 4

4 · Aravive, Inc. · Filed Jan 24, 2020

Insider Transaction Report

Form 4
Period: 2020-01-22
McIntyre Gail Frances
Chief Scientific Officer
Transactions
  • Award

    Stock Option

    2020-01-22+48,58348,583 total
    Exercise: $10.84From: 2020-02-22Exp: 2030-01-21Common stock (48,583 underlying)
Footnotes (1)
  • [F1]These options vest pro rata on a monthly basis over four (4) years commencing on the one month anniversary of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION